Entering text into the input field will update the search result below

Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2020 Results - Earnings Call Transcript

Mar. 01, 2021 10:51 PM ETAtara Biotherapeutics, Inc. (ATRA)
SA Transcripts profile picture
SA Transcripts

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q4 2020 Earnings Conference Call March 1, 2020 4:30 PM ET

Company Participants

Eric Hyllengren - VP, IR & Finance

Pascal Touchon - President and CEO

Jakob Dupont - EVP and Global Head, Research & Development

AJ Joshi - CMO

Kristin Yarema - CCO

Conference Call Participants

John Newman - Canaccord

Salim Syed - Mizuho

Michael DiFiore - Evercore

Anupam Rama - JPMorgan

Ernie Rodriguez - Cowen and Co.

Matt Phipps - William Blair

Ken Chan - Jefferies


Good afternoon everyone. Thank you for standing by and welcome to the Atara Biotherapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to hand the conference over to your speaker today, Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.

Eric Hyllengren

Thank you, operator. Good afternoon everyone and welcome to Atara’s fourth quarter and full year 2020 results conference call. On today's call, members from the Atara executive team will provide an update on our 2020 financial results and operational progress and also review our upcoming key milestones and objectives.

Earlier today, we issued a press release announcing our fourth quarter and full year 2020 financial results and operational progress. This press release and an updated investor presentation are available in the Investor & Media section at atarabio.com.

Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive Officer; Dr. Jakob Dupont, Executive Vice President and Global Head of Research and Development; Utpal Koppikar, Chief Financial Officer; Joe Newell, Chief Operations Officer; Dr. AJ Joshi, Chief Medical Officer; and Kristin Yarema, Chief Commercial Officer.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.